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CONSPECTUS: Over the past decades, major eﬀorts were undertaken to
develop devices on a nanoscale level for the eﬃcient and nontoxic delivery of
molecules to tissues and cells, for the purpose of either diagnosis or treatment
of disease. The application of such devices in drug delivery has proven to be
beneﬁcial for matters as diverse as drug solubility, drug targeting, controlled
drug release, and transport of drugs across cellular barriers. Multiple
nanotherapeutics have been approved for clinical treatment, and more
products are being evaluated in preclinical and clinical trials. However, many
biological barriers hinder the medical application of nanocarriers. There are
two main classes of barriers that need to be overcome by drug nanocarriers:
extracellular and intracellular barriers, both of which may capture and/or
destroy therapeutics before they reach their target site. This Account discusses
major biological barriers that are confronted by nanotherapeutics, following
their systemic administration, focusing on cellular entry and endosomal escape
of gene delivery vectors. The use of pH-responsive materials to overcome the endosomal barrier is addressed.
Historically, cell biologists have studied the interaction between cells and pathogens in order to unveil the mechanisms of
endocytosis and cell signaling. Meanwhile, it is becoming clear that cells may respond in similar ways to artiﬁcial drug delivery
systems and, consequently, that knowledge on the cellular response against both pathogens and nanoparticulate systems will aid
in the design of improved nanomedicine. A close collaboration between bioengineers and cell biologists will promote this
development. At the same time, we have come to realize that tools that we use to study fundamental cellular processes,
including metabolic inhibitors of endocytosis and overexpression/downregulation of proteins, may cause changes in cellular
physiology. This calls for the implementation of reﬁned methods to study nanocarrier−cell interactions, as is discussed in this
Account.
Finally, recent papers on the dynamics of cargo release from endosomes by means of live cell imaging have signiﬁcantly
advanced our understanding of the transfection process. They have initiated discussion (among others) on the limited number
of endosomal escape events in transfection, and on the endosomal stage at which genetic cargo is most eﬃciently released.
Advancements in imaging techniques, including super-resolution microscopy, in concert with techniques to label endogenous
proteins and/or label proteins with synthetic ﬂuorophores, will contribute to a more detailed understanding of nanocarrier-cell
dynamics, which is imperative for the development of safe and eﬃcient nanomedicine.
1. INTRODUCTION
Overcoming biological barriers remains a major challenge in
the eﬀective delivery of therapeutic agents to diseased sites.
Indeed, such barriers exist in the process of accomplishing an
appropriate biodistribution, but also in cellular uptake and
intracellular routing. Approaches to overcome these barriers
have received signiﬁcant attention over the past decades.
Among others, advances in nanotechnology have improved the
delivery of therapeutics via nanosized carriers to desired tissues
and cells. In the ﬁeld of gene delivery, nanoparticles have been
translated to the clinic as a promising platform. However, most
of the nanocarriers, belonging to the class of nonviral vectors,
are still primarily in a developing, preclinical stage because of
their relative delivery ineﬃciency, when compared to viral
vectors.1,2 Apart from being confronted with various
extracellular hurdles, additional barriers arise for nanocarriers
when they encounter the target cells. Eﬀective internalization
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and subsequent release of their cargo, requiring translocation
across endosomal and/or nuclear membranes, constitute an
additional parameter in determining therapeutic eﬃciency, and
hence, potential clinical impact. Therefore, special properties
are required for nanocarriers to cope with refractory extra- and
intracellular conditions, both in vivo and in vitro, which also
include issues of (transient) stability and low cytotoxicity. A
better understanding of nanocarrier−cell interactions will help
to increase the eﬃcacy, safety, and clinical translation of
nanocarriers.
2. CELLULAR UPTAKE OF GENE DELIVERY VECTORS
Gene delivery with nonviral vectors, including lipoplexes and
polyplexes, still suﬀers from limited eﬃciency compared to
viral gene delivery. To optimize nonviral gene delivery, a
detailed understanding of the mechanisms through which the
genetic cargo is delivered into a cell is vital. In 1995, Wrobel
and Collins showed that lipoplexes, i.e., complexes between
cationic lipids and nucleic acids, do not fuse with the plasma
membrane of cells to deliver their genetic cargo into the
cytoplasm, but become internalized via the process of
endocytosis.3 In order to achieve a therapeutic eﬀect, the
nucleic acids need to reach the desired cell compartment, i.e.,
the nucleus for DNA or the cytosol for RNA. As a result, the
endosomal membrane constitutes a barrier for the release of
genetic cargo from endocytosed gene vectors into the cytosol
(Figure 1).
2.1. Endocytosis of Gene Delivery Vectors
Typically, endocytosis is subdivided in pinocytosis and
phagocytosis, where pinocytosis includes clathrin-mediated
endocytosis (CME), caveolae-mediated endocytosis, ﬂuid
phase endocytosis, and macropinocytosis. How these diﬀerent
pathways are regulated is largely unclear, and is dependent on
cell type and cell state.4
By the use of biochemical and genetic approaches to inhibit
endocytosis, and monitoring simultaneously clathrin-mediated
endocytosis of transferrin, Zuhorn et al. showed that CME is
the major entry pathway for SAINT-2/DOPE lipoplexes in
COS-7 cells.5 This was the ﬁrst report in which a speciﬁc type
of endocytosis, namely, CME, was linked to productive
transfection with lipoplexes. Later, branched PEI (BPEI)
polyplexes were shown to enter HeLa cells via multiple
Figure 1. Endocytosis of gene delivery particles. (1) Binding of gene delivery particles to the cell surface, through electrostatic interactions between
the positively charged particles and the negatively charged cell surface and/or ligand−receptor interaction, results in their endocytosis. (2)
Interaction of the particles with the endosome causes destabilization of the particles and the endosomal membrane. (3) Genetic cargo that has
dissociated from the particle is released into the cytosol through the endosomal membrane destabilization.
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endocytic pathways, including CME, macropinocytosis, and
caveolae.6−8 (Nontargeted) lipoplexes and polyplexes have
been shown to bind to cells via adhesion receptors, including
integrins and syndecans.9−12 To improve delivery to speciﬁc
cell types, functionalization of the nanoparticle surface with
ligands that target cell-speciﬁc receptors is successfully used in
vitro as well as in vivo.13−16
2.2. Reﬁned Methods to Study Endocytosis
Chemical inhibitors of endocytosis are widely used to study the
involvement of speciﬁc uptake routes. They act quickly, and
their action is often reversible. However, chemical inhibitors of
endocytosis almost never completely nor speciﬁcally block one
endocytic pathway, and may induce cellular toxicity.17 For
example, Pitstop 2, a clathrin inhibitor, was shown to also
inhibit clathrin-independent endocytosis.18 Therefore, the
eﬀect of an endocytosis inhibitor on the uptake of a speciﬁc
nanocarrier should be compared to its eﬀect on the uptake of
reference substances.19,20 Also, colocalization of a nanocarrier
with reference substances may be helpful in determining its
route of entry. Transferrin is a bona ﬁde cargo for the clathrin-
mediated endocytosis pathway. However, the possibility of
direct binding of transferrin to the nanoparticle under
investigation, which could result in false-positive colocalization,
should be excluded. In addition, one should take into account
the diﬀerence in kinetics between transferrin and nanocarrier
uptake. Typically, transferrin uptake reaches near maximum
levels after 10 min of incubation,21 while nanoparticles (∼100
nm) reach maximum uptake after several hours. Importantly,
colocalization of nanoparticles with clathrin, especially after
prolonged incubation times, is not a proof for the involvement
of clathrin-mediated endocytosis, because clathrin is also
involved in the pinching oﬀ of vesicles from sorting
endosomes, i.e., in the further processing of endosomes that
occurs af ter the internalization event at the plasma membrane.
Cholera toxin B is often used as a marker cargo for caveolar
endocytosis, but can also be internalized via routes that do not
involve caveolae.22,23 Since caveolae seem to be instrumental in
the uptake of excess glycosphingolipids, the glycosphingolipid
lactosylceramide (LacCer) may be a better marker for caveolar
endocytosis.24
Next to the use of marker cargoes for speciﬁc routes of
endocytosis, colocalization studies by means of overexpression
of ﬂuorescent fusion proteins of key endocytic regulators or
immunostaining for these regulators can be helpful in
determining routes of uptake for nanocarriers. In addition,
downregulation of endocytic proteins and overexpression of
dominant negative forms is being used to pinpoint the
involvement of speciﬁc routes of uptake. However, over-
expression of wildtype and dominant negative forms of
proteins, by means of plasmid constructs that are typically
under the control of strong promotors such as the CMV
promotor, may cause artifacts.25,26 For example, overexpression
of caveolin-GFP may result in its accumulation in endolyso-
somes without prior localization in caveolae, which has been
mistaken for localization in caveolae-positive endosomes.27
The CRISPR/Cas9 genome editing technique allows for the
expression of genes under the control of their natural
promotor, preventing cellular defects that may occur due to
protein overexpression. Shvets et al. used CRIPSR/Cas9 to
generate double genome-edited cells, expressing caveolin1-
GFP and cavin 1-mCherry.28 Because both caveolin and cavin
proteins are needed to form caveolae, the combined presence
of caveolin and cavin in vesicles, reveals the presence of intact
caveolar vesicles. The ﬂuorescent tagging of endogenous
endocytic proteins by means of CRISPR/Cas9 permits the
visualization of endocytosis under physiological conditions.
However, this method is limited to genetically encoded
ﬂuorophores, i.e., ﬂuorescent proteins. This may be disadvanta-
geous because a “bulky” ﬂuorescent tag may hinder
interactions of the ﬂuorescently tagged protein with cellular
components, thereby disturbing its physiological function.
In order to label intracellular proteins with (smaller)
synthetic ﬂuorophores, cells can be genetically encoded with
SNAP-tag, and -subsequently- be incubated with membrane-
permeable benzylguanine-ﬂuorophores, leading to the for-
mation of a covalent bond between the SNAP-tag and the
benzylguanine-ﬂuorophore.29 Introduction of a disulﬁde bond
in between the benzylguanine group and the ﬂuorophore gives
the possibility to cleave the ﬂuorophore from the protein by
means of a reducing agent. A cell-impermeable reducing agent
can then be used to cleave the label that is present
extracellularly, permitting speciﬁc labeling of the intracellular
pool of SNAP-tagged protein. Bitsikas et al. used a GPI-
anchored SNAP-tag construct to detect internalized GPI-AP
with very high eﬃciency and low background.30 Moreover,
spectroscopic properties of synthetic ﬂuorophores are often
better than that of ﬂuorescent proteins, which is especially
important for applications in live cell imaging. In the same
work, Bitsikas et al. used biotinylation of the entire pool of
plasma membrane proteins to deﬁne all primary endocytic
vesicles. They showed that ∼95% of endocytic vesicles
originated from clathrin-mediated endocytosis. Moreover,
they showed that CME is the main pathway for uptake of
GPI-anchored proteins, which is commonly believed to occur
via the CLIC/GEEC pathway.31 Inhibition of CME, through
overexpression of C-terminal AP180 (AP180/C) or dominant-
negative dynamin (K44A), led to a reduction in uptake of the
GPI-anchored protein CD59. Strikingly, in cells overexpressing
an AP2 mutant deﬁcient in binding the transferrin receptor,
transferrin uptake was signiﬁcantly reduced, whereas the
uptake of CD59 was signiﬁcantly increased. Since GPI-
anchored proteins lack the cytosolic domains that are typically
recognized by adaptor proteins to recruit receptors to coated
pits in receptor-mediated endocytosis, they reasoned that GPI-
APs are normally excluded from coated pits by steric crowding
eﬀects. These data suggest that elimination of adaptor protein-
mediated recruitment of receptors to coated pits alleviates the
steric exclusion of GPI-anchored proteins. Thus, perturbations
of coated pit formation may have a more severe impact on high
aﬃnity proteins, such as the transferrin receptor, than low
aﬃnity proteins, such as CD59.30
Taking into account the perturbations of physiological
processes that may be induced by the commonly used methods
to study endocytosis, a thorough (re)investigation of the
cellular traﬃcking pathways of gene delivery vectors by means
of the aforementioned reﬁned methods, including the
execution of proper controls, is warranted. Paradoxically,
transfection of cells (by means of gene delivery vectors) is a
method that is widely used in the study of endocytosis, and
may cause signiﬁcant (temporary) changes in endocytic
processes. For example, transfection of cells with PEI
polyplexes was shown to cause a reduction in the number of
early endosomes.32 Moreover, transfection with both lip-
oplexes and polyplexes has been linked to the induction of
autophagy.33
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3. INTRACELLULAR PROCESSING OF GENE DELIVERY
DEVICES
The processing of endosomes within the various uptake
pathways diﬀers and may consequently inﬂuence opportunities
for endosomal escape and release of cargo into the cytoplasm,
as mediated by gene vectors. Especially, because the
mechanisms of endosomal escape diﬀer between diﬀerent
types of gene vectors. For instance, the endosomal escape of
lipoplexes involves lipid mixing between cationic lipids in the
lipoplex with anionic lipids in the endosomal membrane, and is
pH-independent.34 On the contrary, the endosomal escape of
polyplexes, i.e., complexes between cationic protonatable
polymers and nucleic acids, is dependent on endosomal
acidiﬁcation. Speciﬁcally, the endosomal escape of polyplexes
has been suggested to result from their H+ buﬀering capacity
resulting in enhanced Cl- accumulation within the endosome
and eventually osmotic lysis of the endosomal membrane
(proton sponge eﬀect).35 While branched PEI (BPEI)
polyplexes were shown to enter HeLa cells via CME,
macropinocytosis, and caveolae, only the uptake of polyplexes
via caveolae resulted in productive transfection.8 Transfection
by polyplexes via a pH neutral caveolar pathway would not be
supportive for the fact that polyplex-mediated endosomal
escape of genetic cargo is dependent on endosomal acid-
Figure 2. Endosomal escape mediated by gene delivery particles. (A) In lipoplex-mediated gene delivery, ODN (green) release from multiple
endosomes results in gradual accumulation of ODNs in the nucleus. (B) In polyplex-mediated gene delivery, a burst release of the genetic cargo
from typically only one or two endosomes per cell, with a complete discharge of the nucleic acid content from the endosome into the cytosol,
results in instantaneous accumulation of ODNs in the nucleus. (A, B) Graphs show the ﬂuorescence intensity of particles, cytoplasm and nucleus
over time. Adapted with permission from ref 49. Copyright 2013 American Chemical Society. (C) Glycoplexes (green) are initially present in early
and late endosomes (red). They are released intact in the cytosol where they disassemble. Adapted with permission from ref 57. Copyright 2018
American Chemical Society.
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iﬁcation, i.e., the proton sponge theory. However, it has been
shown that endosomes from distinct endocytic pathways may
merge, which would allow for acidiﬁcation of vesicles originally
derived from caveolae.36
Remarkably, when polyplex-containing endosomes in the
CME pathway were halted, by means of PKA inhibition, at a
stage between early and late endosomes, they contributed to
the overall transfection.8 Speciﬁcally, localization of BPEI
polyplexes in transferrin−/rab9−/LAMP1− endosomal com-
partments resulted in eﬀective endosomal escape of genetic
cargo.8 Probably, polyplex-mediated endosomal swelling and/
or polyplex dissociation within the CME pathway is too slow
to induce endosomal escape prior to polyplex accumulation in
degradative lysosomal compartments. Therefore, “freezing” the
endosomal processing, by means of PKA inhibition, at a
prelysosomal stage broadens the window of opportunity for
release of genetic cargo from polyplex-containing endosomes
within the CME pathway, thereby enhancing transfection
eﬃciency. A similar intracellular compartment, i.e., maturing
endosomes, was found as the site for endosomal escape of
Figure 3. Old and new model for cationic lipid-mediated endosomal escape of genetic cargo. The fusion pore model (left column) proposes that
nucleic acid release into cytosol occurs through fusion of the lipoplex with the endosome membrane, initiated by ﬂip-ﬂop of anionic PS lipids from
the outer leaﬂet of the endosome to the inner leaﬂet. The transient pore model (right column) proposes that nucleic acid release into cytosol occurs
via transient pores in the endosome membrane. LBPA in the inner leaﬂet of the endosome membrane may play a role in membrane
permeabilization.
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siRNA in lipoplex- and LNP-mediated delivery.37,38 Appa-
rently, irrespective of the diﬀerent mechanisms that are
involved in endosomal escape mediated by lipoplexes and
polyplexes, the compartment that allows for their eﬀective
escape seems to be the same, which may suggest a common
denominator in the two seemingly distinct mechanisms. The
coformulation of drugs that halt gene vectors at a “release-
prone” endosomal stage may be useful in the development of
improved gene delivery vectors. Likewise, osmotic lysis of
endosomes, for example via nigericin-mediated K+/H+
exchange,39 may facilitate endosomal escape.
4. ENDOSOMAL ESCAPE OF GENE DELIVERY
DEVICES
4.1. Lipoplex-Mediated Endosomal Escape
In the early days of nonviral gene delivery research, structure−
function-activity relationships were primarily found by
determining the physicochemical characteristics of lipoplexes
and correlating those with transfection performance.40−43
Major insight in the mechanism of lipoplex-mediated trans-
fection was given by the investigation of lipid conformation by
small-angle X-ray scattering (SAXS). Koltover et al. showed
that an inverted hexagonal phase of lipoplexes, as opposed to a
lamellar phase, stimulated DNA release from lipoplexes upon
their incubation with anionic vesicles, which served as a mimic
of the endosomal membrane.44 They proposed a correlation
between nonlamellar lipid organization in lipoplexes with
transfection eﬃciency. The correlation between a nonbilayer
phase of the lipoplex and its high transfection activity is still
being reported in literature,45,46 but does not seem to be a
general ﬁnding. For example, Tassler et al. found that lysine-
based amino-functionalized lipids, that varied in their chain
length and (un)saturation, formed cubic or lamellar lipoplexes.
The lamellar lipoplexes were the most eﬃcient in trans-
fection.47 Logically, for eﬃcient transfection, a lipoplex should
induce nonbilayer phase structures upon interaction with
anionic lipids at the endosome membrane but does not need to
be in a nonbilayer conformation by itself. Indeed, Zuhorn et al.
reported a correlation between the nonlamellar lipid phase of
lipoplexes af ter incubation with anionic vesicles, and high in
vitro transfection eﬃciency. This was supported by an eﬃcient
endosomal escape of genetic cargo, as measured by the nuclear
accumulation of oligonucleotides (ODNs) in cells.48 Overall, it
is important to conﬁrm the endosomolytic potential of
nanocarriers, as determined by certain biophysical and/or
structural characteristics, using cell-based assays to quantify the
endosomal escape of nucleic acids.
Recently, by taking a live cell imaging approach to determine
the intracellular processing of nonviral gene vectors, an
important breakthrough in elucidation of the endosomal
escape of nucleic acids was achieved. Speciﬁcally, incubation
of HeLa cells with Lipofectamine2000 lipoplexes, comprising
ﬂuorescently labeled lipids and nucleic acid cargo (ODNs),
revealed ODN release from multiple endosomes resulting in a
gradual accumulation of ODNs in the nucleus (Figure 2A).49
Release of genetic cargo from endosomes into the cytosol was
suggested to occur via transient pores (Figure 3; right
column),49 and not through fusion of the lipoplex with the
endosome membrane (Figure 3; left column).34 Using a
similar live cell imaging approach, Wittrup et al. showed the
release of siRNA from endosomes in lipoplex- and LNP-
mediated delivery. They observed between one and ﬁve release
events per cell over several hours, with an incomplete release of
genetic cargo from endosomes.37
The identiﬁcation of a release-prone endocytic compart-
ment, as discussed above, has initiated discussion on the
involvement of a speciﬁc class of anionic lipids in mediating
endosomal escape. Durymanov and Reineke questioned why
lipoplexes release their genetic payload from maturing
endosomes,50 because the anionic phosphatidyl serine (PS)
lipid content in maturing endosomes is less than in early
endosomes,51 while anionic PS at the cytoplasmic leaﬂet of the
endosome has been held responsible for inducing endosomal
escape (Figure 3; left column).34 They suggest that LBPA at
the limiting membrane of multivesicular bodies (MVBs) is the
mostly likely candidate for inducing endosomal release of
genetic cargo (Figure 3; right column). To our knowledge, no
studies have (yet) been undertaken to investigate the lipid
compositions of endosomes from diﬀerent endocytic pathways
and/or at diﬀerent stages of maturation in relation to delivery
eﬃciency by speciﬁc carrier systems. Recent advances in mass
spectrometry for lipidomics make it feasible to embark on such
studies.
4.2. Polyplex-Mediated Endosomal Escape
Polyplexes are considered to escape from endosomes through
the proton sponge eﬀect, an osmotically induced swelling of
the endosome, triggered by the proton buﬀering capacity of the
polyplexes, which results in rupturing of the endosomal
membrane.35 However, increasing evidence indicates that the
proton sponge eﬀect is not the only reason for polyplex-
mediated endosomal escape of genetic cargo. Although
PEGylation is a useful strategy to prolong the circulation
time of nanoparticles in vivo by avoiding their rapid capture
and clearance by undesired tissues and cells, such as
macrophages, it also compromises endosomal release, known
as the “PEG dilemma”. It has been well documented that the
use of polyethylene glycol (PEG) in order to create long-
circulating nanoparticles, inhibits the endosomal escape of
lipoplexes as well as polyplexes.52−55 For lipoplexes this is
expected as a hydrophilic PEG layer will prevent the intimate
contact between lipoplex and endosome membrane, that is
required for lipid mixing and, consequently, endosomal escape.
However, PEGylation of polyplexes is not expected to
inﬂuence the proton buﬀering capacity of the polymers.
Therefore, since PEG prevents endosomal escape of
polyplexes, it seems reasonable to suggest that in addition to
the proton sponge eﬀect an intimate contact between polymers
and the endosomal membrane is required for endosomal
destabilization and nucleic acid release into the cytosol.
Indeed, protonation of polymers will -next to endosome
swelling- also cause polymer swelling due to electrostatic
repulsion between the protonated polymers. These protonated
polymers will show enhanced electrostatic interaction with the
endosomal membrane. Coarse-grained molecular dynamics
simulations showed that adsorption of polymers to a
membrane under tension, as induced by osmotic swelling
and the increase in polymer size, may lower the critical stress
that disrupts the membrane.56 Therefore, cooperation of
osmotic pressure and local membrane permeation by
(expanded) polymer chains likely is responsible for eﬃcient
endosomal rupture.
By means of live cell imaging on a spinning disk confocal
microscope, Rehman et al. showed the involvement of an
endosomal burst in polyplex-mediated delivery of nucleic acids,
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providing direct evidence for osmotic rupture of endosomes
through the so-called proton sponge eﬀect.49 Speciﬁcally,
incubation of cells with LPEI polyplexes, comprising
ﬂuorescently labeled polymers and ODNs, presented a burst
release of the genetic cargo from typically only one or two
endosomes per cell, with a complete discharge of the nucleic
acid content from the endosome into the cytosol (Figure 2B).
Interestingly, a seemingly vectorial release of genetic cargo
from a polyplex-containing endosome was observed, hinting to
the involvement of local destabilization of the endosomal
membrane.49 On the contrary, by means of super-resolution
imaging (STORM) of ﬁxed cells, intact cationic glycogen-
siRNA complexes (glycoplexes) were shown to be released
from endosomes, while glycoplex disassembly occurred in the
cytosol (Figure 2C).57 Because glycoplexes behave as rigid
globular spheres, association of glycogen chains with the
endosomal membrane likely is prevented. It was therefore
concluded that endosome rupture by glycoplexes is exclusively
determined by endosome swelling, i.e., without a role for
permeation of the endosomal membrane by expanded
polymers.57 Whether local destabilization of the endosome
membrane by positively charged (expanded) polymer (chains)
facilitates the endosomal rupture induced by polyplexes
remains unclear, and may be dependent on cell type, carrier
type, and/or type of cargo. The combination of super
resolution microscopy with live cell imaging will provide
exciting opportunities to study nanocarrier−cell interactions,
which is expected to give even more detailed information on
the dynamics of endocytosis and cargo release from endo-
somes.58
5. STIMULI-RESPONSIVE MATERIALS FOR
NANOCARRIER STABILITY IN CIRCULATION AND
CONTROLLED RELEASE OF CARGO AT THE
TARGET SITE
Over the past decades, numerous nanoparticle platforms have
been investigated for drug delivery, including liposomes,
polymeric nanoparticles, dendrimers, and inorganic/semi-
inorganic nanoparticles. Although these materials (mostly
polymers and lipids) account for >80% of the therapeutic
nanoparticles that are in clinical use, there now is a tendency to
develop stimuli-responsive nanoparticle platforms that are
sensitive to speciﬁc signals and that may contribute to site-
speciﬁc drug delivery.59 Exogenous stimuli-responsive drug
delivery systems respond to noninvasive physical triggers,
including light, heat, ultrasound, and magnetic ﬁeld, while
Figure 4. Stimuli-responsive nanomaterials for gene delivery. (A) Nanocarrier coated with PEG via an acid- or reduction-labile linker. Removal of
the PEG coating occurs at acidic pH (in endosome) or in a reducing environment (in endosome?, cytosol, nucleus), respectively.61,63,73 (B)
Polyplex with pH-sensitive PEI. Low molecular weight PEI chains are linked via acid-labile bonds. Upon acidiﬁcation (in endosome), the cross-
linker is degraded. This approach combines the advantages of high molecular weight PEI (high transfection eﬃcacy) and low molecular weight PEI
(low cytotoxicity).62 (C) Ionizable lipid. At acidic pH, the lipids are positively charged, inducing electrostatic interaction with negatively charged
nucleic acids. At physiological pH, the lipid−nucleic acid complex has a near-neutral charge, promoting long blood circulation time. At acidic pH
(in endosome), the lipids become positively charged and destabilize the endosomal membrane, leading to the release of nucleic acids in the
cytosol.64−67 (D) pH-Responsive thermogelling polymer. The polymer is water-soluble at 4 °C and forms a solid gel at 37 °C, at physiological pH.
Encapsulation of nucleic acids occurs at the sol−gel transition. At acidic pH (in endosome), the pH-sensitive moiety (red) is protonated and the gel
solubilizes, releasing its cargo.69 (E) pH-Responsive block copolymer. The copolymer consists of a hydrophilic pH-insensitive polymer (green) and
a polymer that is hydrophobic at neutral pH, whereas it becomes protonated and turns hydrophilic at a low pH (pH < pKa).
71 Block copolymers are
loaded with nucleic acids through a pH switch method. At endosomal pH, the copolymer turns hydrophilic, which will lead to complex
dissociation.70−72
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endogenous stimuli-responsive systems respond to speciﬁc
biochemical conditions, such as a change in pH, redox state, or
the presence of speciﬁc enzymes.60 Distinct enveloped viruses
that enter cells via endocytosis, exploit this pathway by a
required pH-dependent change in one of the viral proteins
(such as hemagglutinin (HA) protein of the inﬂuenza virus)
that facilitates fusion between the viral envelope and the
endosomal membrane, thereby causing endosomal escape of
the viral RNA and/or DNA. Inspired by this strategy, a
concept for applying pH-sensitive nanoparticles has been
proposed, involving nanoparticles that are stable at physio-
logical pH, but dissociate at mild acidic pH. For example, pH-
sensitive nanocarriers can be prepared from lipids or polymers
that contain acid-labile bonds that trigger particle dissociation
and drug release upon a decrease in pH (Figure 4 A,B).61−63
Such a decrease in pH occurs, e.g., in the interstitial ﬂuid of
tumors or within endosomes upon endosomal maturation. The
use of acid-labile nanocarrier components may provide a
potential solution for the “PEG dilemma”, i.e., the prolongation
of blood circulation time of gene vectors upon their pegylation
that goes at the expense of their endosomal escape capacity.
Chan et al. recently reported that PEGylated cationic
liposomes containing a new acid-labile PEG-lipid were able
to destabilize the endosomal membrane and induce eﬃcient
transfection.63
5.1. Ionizable Lipids in Lipid Nanoparticle (LNP) Systems
for Gene Delivery
Recent development of lipids and polymers that display pH-
induced structural changes aim for the generation of
nanocarriers that are stable in the blood circulation thanks to
their (near) neutral charge at physiological pH, for in vivo gene
delivery purposes. A low pH-induced membrane-destabilizing
activity provides those carriers with the necessary endo-
somolytic activity to release their genetic cargo into the
cytoplasm. Cullis and co-workers developed lipid nanoparticles
(LNPs) with ionizable aminolipids, e.g., 1,2-dioleoyl-3-
dimethylammonium propane (DODAP) and heptatriaconta-
6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate (DLin-
MC3-DMA), that change to a cationic form under acidic
conditions.64,65 At acidic pH the aminolipids eﬀectively
complex (negatively charged) nucleic acids (DNA, RNA).
When, after complex formation, the pH is neutralized (∼pH
7), the complexes exhibit a near-neutral surface charge, which
prolongs their blood circulation time. Due to endosomal
acidiﬁcation during the endocytic processing of the complexes,
the aminolipids again become cationic (Figure 4C). Close
proximity between the LNP and the endosomal membrane
allows for lipid mixing and the formation of ion pairs between
the cationic lipids and anionic lipids within the endosome,
which induces inverted nonbilayer conformations that exert a
membrane-destabilizing eﬀect. This will result in the release of
the genetic cargo into the cytoplasm. Although the ionizable
lipids DLin-KC2-DMA and DLin-KC4-DMA showed com-
parable pKa values, and bilayer-to-hexagonal HII transition
temperatures (TBH) when mixed with anionic lipids, they
showed a >30-fold diﬀerence in in vivo transfection activity.66
In this study, the TBH was determined by diﬀerential scanning
calorimetry of a suspension of ionizable lipids premixed with
the anionic lipid DSPS. However, premixing of cationic
(ionizable) lipids and anionic lipids may not properly reﬂect
the situation in cells where the cationic lipids ﬁrst need to gain
access to the LNP−endosomal membrane interface. This
property is likely inﬂuenced by the length and ﬂexibility of the
spacer between the charged lipid headgroup and the lipid tails,
as DLin-KC2-DMA and DLin-KC4-DMA only diﬀer in spacer
group.66 As previously mentioned, cell-based assays to quantify
the endosomal escape of genetic cargo are important to
conﬁrm the endosomolytic potential of nanocarriers, as
determined by physicochemical analyses, and are instrumental
in screening gene delivery vectors for transfection activity.
Recently, Sato et al. synthesized a new pH-sensitive cationic
lipid YSK05 that was incorporated in LNPs for gene silencing.
With their LNP formulation, that required prior complexation
of siRNA with protamine for eﬃcient loading with siRNA, they
achieved in vitro (in HeLa cells) and in vivo (by direct tumor
injection) siRNA-mediated gene silencing.67 Likewise, pH-
sensitive amino lipids have been successfully employed for
DNA delivery.68
5.2. pH-Sensitive Block Copolymers for Gene Delivery
Next to pH-sensitive lipids, pH-sensitive block copolymers are
investigated for drug delivery purposes. Recently, block
copolymers with poly(N,N′-diethylaminoethyl methacrylate)
(PDEAEM) were prepared to increase the hydrophilicity of
the polymer and improve drug loading. These block
copolymers formed hydrogels at body temperature, and drug
release from these gels was inﬂuenced by the environmental
pH (Figure 4D).69 The diblock copolymer poly(2-methacry-
loyloxyethyl phosphorylcholine)-b-poly(2-(diisopropylamino)-
ethyl methacrylate) (PMPC-PDPA) was successfully employed
for siRNA delivery.70 PDPA has a pKa of 6.4. It is hydrophobic
at neutral pH, whereas it becomes protonated and turns
hydrophilic at a pH < 6.4.71 Similar to LNPs containing
ionizable aminolipids, PMPC-PDPA block copolymers could
be loaded with siRNA at acidic pH. It is postulated that after
their uptake by cells, the polymers become hydrophilic at
endosomal pH, which will lead to complex dissociation (Figure
4E). This will lead to release of the genetic cargo, and at the
same time generate osmotic stress within the endosomes, that
in turn will lead to endosomal rupture and release of the
genetic cargo in the cytoplasm. However, inclusion of the pore
forming drug amphotericin B was required to obtain eﬀective
endosomal escape of siRNA when using another PDPA block
copolymer for delivery, i.e., poly(2-(dimethylamino)ethyl
methacrylate PDMA−PDPA,72 indicating that here PDPA-
generated osmotic stress was not suﬃcient for inducing
endosomal disruption. Alternatively, dual responsive systems
that combine, e.g., pH- and redox-responsiveness may improve
endosomal destabilization. Zhu et al. made a pH/redox dual-
responsive mPEG−PLA-PHis-ssOEI polyplex.73 The structure
change of this polyplex at low pH led to exposure of the redox
cleavable disulﬁde bridges, promoting complex dissociation
and endosome membrane destabilization. Of note, the N/P
ratio turned out to be an important determinant for complex
dissociation, because at high N/P ratio (10) enhanced nucleic
acid binding due to protonation at low pH, counteracted the
complex dissociation induced by the hydrophobic−hydrophilic
switch of the polymer.73
6. CONCLUSIONS AND PERSPECTIVES
The exact parameters that would determine and/or predict the
quality of a perfect drug/gene nanocarrier, ready for clinical
use, remain largely enigmatic and diﬃcult to deﬁne. Clearly,
issues of concern are stability, high-eﬃciency, low-cytotoxicity,
large payload, potency of production scale-up, economics, etc.
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Even though major eﬀorts have been undertaken over the past
decades to develop nanoscale materials for the delivery of
(therapeutic) molecules, for disease diagnosis and treatment,
the outcome has not yet met the expectations. As an example,
of nonviral vectors only a few modiﬁed lipid- and polymer-
based nanocarriers have entered the clinical trial phase, while
viral vectors constitute approximately 70% of the clinical
trials.1,2 Though safety concerns partly restrict the application,
low eﬃciency seems a major limitation for nonviral vectors so
far. Many in vitro well-evaluated nonviral vectors fail to cross
the biological barriers in vivo, therefore resulting in low
eﬃciency. Improvement of physical-chemical and biological
activity of nonviral vectors is therefore still urgently needed.
In nature, several pathogens and secreted toxins use speciﬁc
strategies for crossing extracellular and intracellular biological
barriers in order to enter host cells. The molecular mechanisms
that are involved in the host cell invasion by pathogens have
inspired the development of biomimetic nanocarriers for drug
delivery. Various studies have estimated that optimized surface
modiﬁcation with pathogen-derived molecules improves
selective delivery in the biological system. The development
of biomimetic nanocarriers for drug/gene delivery is a rapidly
emerging ﬁeld, which exploits advantages of molecular
mechanism used by pathogens. However, this concept is still
in progress, and whether safety poses a risk in copying these
strategies requires further studies. An increase in knowledge on
how pathogens control host cell signaling and invasion, and
advances in the synthesis of novel material may hold a
promising and bright future for nanotechnology, especially the
development of stimuli-responsive materials such as a
sensitivity toward pH, temperature, redox, or magnetic ﬁeld.
These innovative materials should lead to a new ﬁeld of site-
speciﬁc and/or programmable drug delivery.
The use of new tools for the exploration of nanocarrier−cell
interactions in vitro and in vivo, including reﬁned methods to
study endocytosis, and advances in ﬂuorescence labeling
strategies and high resolution microscopy techniques will be
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